文献速递前列腺癌

增强现实PSMA-3D引导机器人盆腔淋巴结清扫在前列腺癌中的应用

Augmented Reality PSMA-3D guided robotic pelvic lymph node dissection (PLND) in prostate cancer patients.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2025-11-09

结果显示4例(30%)可疑淋巴结位于PLND模板外,9例(69%)术后病理为pN1,3例(23%)淋巴结转移位于模板外;按区域分析敏感度69%、特异度90%、PPV 52%、NPV 95%、AUC 0.79。

要点

  • AR-PSMA-3D引导可实时识别PSMA-PET可疑淋巴结并指导清扫。
  • 30%患者可疑淋巴结位于标准PLND模板外,23%病理证实模板外转移。
  • 按区域分析NPV达95%,但敏感度69%,微转移检出仍有限。

核心结论

  • AR-PSMA-3D引导PLND可促进PSMA-PET可疑淋巴结切除,包括PLND模板外病变。

研究设计与样本

  • 基于术前PSMA-PET图像构建包含可疑淋巴结的3D分割模型。
  • 患者接受RARP联合AR-PSMA-3D引导PLND,以病理检查为参考标准。

主要发现

  • 4例(30%)患者PSMA-PET可疑淋巴结位于PLND模板外。
  • 9例(69%)患者术后病理为pN1,3例(23%)淋巴结转移位于PLND模板外。
  • 按区域分析,AR-PSMA-3D引导PLND的敏感度69%、特异度90%、PPV 52%、NPV 95%、AUC 0.79。
  • AR-PSMA-3D引导下各可疑区域清扫均未发生术中并发症。

临床怎么用

  • 对PSMA-PET提示miN1-2或miM1a的高危前列腺癌患者,可考虑AR-PSMA-3D引导PLND以定位模板外可疑淋巴结。
  • 术中应结合AR引导与病理结果,注意微转移导致的假阴性可能。

局限性

  • PSMA-PET对微转移的空间分辨率低。
  • 3D模型需手动对齐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Intraoperative identification of suspicious lymph node metastases (LNM) detected at PSMA-PET is key to achieve optimal surgical outcomes of robot-assisted radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). We aim to describe a novel technique of augmented reality (AR)-PSMA-3D guided PLND based on preoperative PSMA-PET for real-time identification of LNM. METHODS: Thirteen patients with high-risk PCa and miN1-2 or miM1a disease at PSMA-PET were prospectively enrolled. 3D segmentation model including suspicious LNM was created from PSMA-PET images. INTERVENTION: Patients underwent RARP with AR-PSMA-3D guided PLND for real-time intraoperative identification of suspicious LNM. Pathologic examination was used as reference standard. KEY FINDINGS AND LIMITATIONS: Four (30%) men had suspicious LNM at PSMA-PET outside the field of the PLND template. The AR-PSMA-3D guided PLND allow to dissect each region with suspected LNM at PSMA-PET with no intraoperative complications. Nine (69%) patients had pN1 disease and three (23%) men had nodal metastases outside the PLND template. The sensitivity, specificity, PPV, NPV and AUC of AR-PSMA-3D guided PLND at a per-region analysis were 69%, 90%, 52%, 95% and 0.79, respectively. LIMITATIONS: low spatial resolution of PSMA-PET for micro-metastases and the need for manual alignment of the 3D model. CONCLUSIONS AND CLINICAL IMPLICATIONS: AR-PSMA-3D guidance for PLND in patients with miN1-N2-M1a disease at PSMA-PET allows to facilitate the resection of suspicious LNM including those outside the PLND template. We propose a novel technique combining AR and PSMA-PET 3D models to guide PLND during RARP in PCa patients. The AR-PSMA-3D guidance for PLND allows a promising real-time identification of suspicious nodes, even outside the PLND template.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Bianchi L, Mottaran A, Bortolani B, et al. Augmented Reality PSMA-3D guided robotic pelvic lymph node dissection (PLND) in prostate cancer patients. Prostate Cancer Prostatic Dis. 2025. PMID: 41207912. doi:10.1038/s41391-025-01024-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。